title: Cardioprotection: The Disconnect Between Bench and Bedside.
authors.affiliation: From Hatter Cardiovascular Institute, University College London, London, UK (X.R., D.M.Y.); and NIHR UCLH Biomedical Research Centre, University College London Hospital, London, UK (D.M.Y.).
authors.forename: Xavier
authors.initials: X
authors.lastname: Rossello
authors.affiliation: From Hatter Cardiovascular Institute, University College London, London, UK (X.R., D.M.Y.); and NIHR UCLH Biomedical Research Centre, University College London Hospital, London, UK (D.M.Y.). d.yellon@ucl.ac.uk.
authors.forename: Derek M
authors.initials: DM
authors.lastname: Yellon
mesh_terms: D000818:Animals; D002316:Cardiotonic Agents / Q000008:administration & dosage*; D006801:Humans; D009203:Myocardial Infarction / Q000503:physiopathology / Q000517:prevention & control*; D015428:Myocardial Reperfusion Injury / Q000503:physiopathology / Q000517:prevention & control*; D019095:Point-of-Care Systems / Q000639:trends*; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage
chemical_list: D002316:Cardiotonic Agents; D058921:Purinergic P2Y Receptor Antagonists
keywords: cytoprotection; myocardial infarction; myocardial reperfusion injury